398 related articles for article (PubMed ID: 19828411)
1. How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?
Rovirosa A; Ascaso C; Ordi J; Arenas M; Valduvieco I; Lejarcegui JA; Pahisa J; Torne A; Biete A
Clin Transl Oncol; 2009 Oct; 11(10):681-7. PubMed ID: 19828411
[TBL] [Abstract][Full Text] [Related]
2. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
[TBL] [Abstract][Full Text] [Related]
3. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy for uterine carcinosarcoma: A retrospective assessment of treatment outcomes.
Yilmaz U; Alanyali S; Aras AB; Ozsaran Z
J Cancer Res Ther; 2019; 15(6):1377-1382. PubMed ID: 31898676
[TBL] [Abstract][Full Text] [Related]
5. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
6. Pathologic prognostic factors in stage I-III uterine carcinosarcoma treated with postoperative radiotherapy.
Rovirosa A; Ascaso C; Arenas M; Ríos I; Del Pino M; Ordi J; Morales J; Gascón M; Pahisa J; Biete A
Arch Gynecol Obstet; 2014 Aug; 290(2):329-34. PubMed ID: 24633893
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1277-87. PubMed ID: 18506484
[TBL] [Abstract][Full Text] [Related]
8. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
9. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
11. [Postoperative radiotherapy of uterine sarcoma: a multicentric retrospective study].
Champetier C; Hannoun-Levi JM; Resbeut M; Azria D; Salem N; Tessier E; Ellis S; Cowen D;
Cancer Radiother; 2011 Apr; 15(2):89-96. PubMed ID: 20674447
[TBL] [Abstract][Full Text] [Related]
12. Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study.
Li Y; Ren H; Wang J
BMC Cancer; 2019 Jul; 19(1):697. PubMed ID: 31307426
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.
Queiroz ACM; Fabri V; Mantoan H; Sanches SM; Guimarães APG; Ribeiro ARG; da Nogueira Silveira Lima JP; Chen MJ; Baiocchi G; da Costa AABA
Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():6-12. PubMed ID: 30771718
[TBL] [Abstract][Full Text] [Related]
14. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
15. Lymphadenectomy in women with endometrial cancer: aspiration and reality from a radiation oncologist's point of view.
Foerster R; Kluck R; Arians N; Rieken S; Rief H; Adeberg S; Bostel T; Schlampp I; Debus J; Lindel K
Radiat Oncol; 2015 Jul; 10():147. PubMed ID: 26179059
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
Int J Clin Oncol; 2016 Feb; 21(1):168-76. PubMed ID: 26084780
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes with intraoperative radiotherapy as a component of treatment for locally advanced or recurrent uterine sarcoma.
Barney BM; Petersen IA; Dowdy SC; Bakkum-Gamez JN; Haddock MG
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):191-7. PubMed ID: 21985942
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors.
Barillot I; Horiot JC; Pigneux J; Schraub S; Pourquier H; Daly N; Bolla M; Rozan R
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):969-78. PubMed ID: 9276361
[TBL] [Abstract][Full Text] [Related]
19. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB;
Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136
[TBL] [Abstract][Full Text] [Related]
20. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K
Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
